Cargando…
Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology
BACKGROUND: There is still no reliable biomarker for the diagnosis of pancreatic adenocarcinoma. Carbohydrate antigen 19–9 (CA 19–9) is a tumor marker only recommended for pancreatic adenocarcinoma follow-up. One of the clinical problems lies in distinguishing between this cancer and other benign pa...
Autores principales: | Ferri, María José, Saez, Marc, Figueras, Joan, Fort, Esther, Sabat, Miriam, López-Ben, Santiago, de Llorens, Rafael, Aleixandre, Rosa Núria, Peracaula, Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726554/ https://www.ncbi.nlm.nih.gov/pubmed/26808421 http://dx.doi.org/10.1371/journal.pone.0147214 |
Ejemplares similares
-
Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma
por: Llop, Esther, et al.
Publicado: (2018) -
Obstructive Jaundice in Chronic Pancreatitis
por: Hollands, M. J., et al.
Publicado: (1989) -
Obstructive jaundice secondary to pancreatic head adenocarcinoma in a young teenage boy: a case report
por: Brahmi, Sami Aziz, et al.
Publicado: (2011) -
Obstructive Jaundice as the Initial Manifestation of Gastric Adenocarcinoma
por: Ansari, Shehbaz M, et al.
Publicado: (2022) -
B-Lymphocytes in the Pathophysiology of Pancreatic Adenocarcinoma
por: Minici, Claudia, et al.
Publicado: (2022)